RB1 Blocking Peptide

Cat# MBS822945-5x5mg

Size : 5x5mg

Brand : MyBiosource

Contact local distributor :


Phone : +1 850 650 7790

RB1 Blocking Peptide – >85% Purity

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS822945

MBS822945 is a blocking peptide targeting RB1. Reactive in Human, Mouse, Rat, Bovine, Dog, Pig. Host: Synthetic. The peptide is used to block Anti-RB1 Antibody reactivity. More details

Product Overview

Online Datasheet in PDF
Product Name
RB1, Blocking Peptide
Full Product Name
RB1 Blocking Peptide
Product Gene Name
RB1 blocking peptide
Product Synonym Names
Retinoblastoma-associated protein; p105-Rb; pRb; Rb; pp110
Host
Synthetic
Species Reactivity
Human, Mouse, Rat, Bovine, Dog, Pig
Form/Format
Lyophilized powder
Purity/Purification
>85%
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Antibody/Peptide Pairs
RB1 peptide (MBS822945) is used for blocking the activity of RB1 antibody (MBS821537)
Molecular Weight
106,159 Da
OMIM
phenotype 614041
Quality Control
The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Applications Tested/Suitable for RB1 blocking peptide
Blocking (BL)
Application Notes for RB1 blocking peptide
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours.

Other Notes

Small volumes of RB1 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for RB1. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
retinoblastoma-associated protein
NCBI Official Synonym Full Names
retinoblastoma 1
NCBI Official Symbol
RB1
NCBI Official Synonym Symbols
RB; pRb; OSRC; pp110; p105-Rb; PPP1R130
UniProt Protein Name
Retinoblastoma-associated protein
UniProt Synonym Protein Names
p105-Rb; pRb; Rb; pp110
Protein Family
Retinoblastoma-associated protein
UniProt Gene Name
RB1
UniProt Synonym Gene Names
Rb
UniProt Entry Name
RB_HUMAN
NCBI Protein Information
retinoblastoma-associated protein; retinoblastoma suspectibility protein; prepro-retinoblastoma-associated protein; protein phosphatase 1, regulatory subunit 130

NCBI Summary for RB1

The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Show more

UniProt Comments for RB1

Rb: retinoblastoma tumor suppressor protein regulates cell proliferation by controlling progression through the G1-phase restriction point. Has three distinct binding domains and interacts with regulatory proteins including the E2F family of transcription factors, c-Abl tyrosine kinase and proteins with a conserved LXCXE motif. Cell cycle-dependent phosphorylation by Cdks inhibits Rb target binding, thus allowing cell cycle progression. Recruits and targets histone methyltransferase suv39h1 leading to epigenetic transcriptional repression.

Protein type: Tumor suppressor; Transcription, coactivator/corepressor; Oncoprotein; Nuclear receptor co-regulator

Chromosomal Location of Human Ortholog: 13q14.2

Cellular Component: nucleoplasm; SWI/SNF complex; Rb-E2F complex; PML body; spindle; chromatin; nucleus

Molecular Function: identical protein binding; protein binding; androgen receptor binding; DNA binding; ubiquitin protein ligase binding; transcription coactivator activity; phosphoprotein binding; transcription factor activity; transcription factor binding; kinase binding

Biological Process: sister chromatid biorientation; viral reproduction; positive regulation of transcription, DNA-dependent; negative regulation of transcription from RNA polymerase II promoter, mitotic; regulation of mitotic cell cycle; neuron maturation; cell cycle arrest; positive regulation of macrophage differentiation; neurite development; negative regulation of epithelial cell proliferation; transcription, DNA-dependent; mitotic cell cycle checkpoint; negative regulation of transcription factor activity; enucleate erythrocyte differentiation; regulation of lipid kinase activity; chromatin remodeling; G1/S-specific transcription in mitotic cell cycle; myoblast differentiation; neuron apoptosis; maintenance of mitotic sister chromatid cohesion; gut development; cell division; neuron morphogenesis during differentiation; negative regulation of smoothened signaling pathway; androgen receptor signaling pathway; Ras protein signal transduction; positive regulation of mitotic metaphase/anaphase transition; striated muscle cell differentiation; negative regulation of protein kinase activity; positive regulation of transcription from RNA polymerase II promoter; mitotic cell cycle; negative regulation of transcription, DNA-dependent; cell cycle checkpoint; G1/S transition of mitotic cell cycle

Disease: Bladder Cancer; Osteogenic Sarcoma; Small Cell Cancer Of The Lung; Retinoblastoma
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with RB1 blocking peptide

 Reference Product  PubMed Publications
 CCND1 blocking peptide  >107 publications with RB1 and CCND1
 CDK4 blocking peptide  >79 publications with RB1 and CDK4
 MDM2 blocking peptide  >65 publications with RB1 and MDM2
 E2F1 blocking peptide  >49 publications with RB1 and E2F1
 E2F3 blocking peptide  >21 publications with RB1 and E2F3
 CDK2 blocking peptide  >19 publications with RB1 and CDK2
 CCNE1 blocking peptide  >10 publications with RB1 and CCNE1
 HDAC1 blocking peptide  >6 publications with RB1 and HDAC1
 RBBP4 blocking peptide  >3 publications with RB1 and RBBP4

Pathways associated with RB1 blocking peptide

 Products by Pathway  Pathway Diagram
 Adipogenesis Pathway antibodies  Adipogenesis Pathway Diagram
 Androgen Receptor Signaling Pathway antibodies  Androgen Receptor Signaling Pathway Diagram
 B Cell Receptor Signaling Pathway antibodies  B Cell Receptor Signaling Pathway Diagram
 Bladder Cancer Pathway antibodies  Bladder Cancer Pathway Diagram
 Bladder Cancer Pathway antibodies  Bladder Cancer Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Cell Cycle, Mitotic Pathway antibodies  Cell Cycle, Mitotic Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram
 Cell Cycle Pathway antibodies  Cell Cycle Pathway Diagram

Diseases associated with RB1 blocking peptide

 Disease Name  Pubmed Publications
 Retinoblastoma Antibodies  >1087 publications with RB1 and Retinoblastoma
 Carcinoma Antibodies  >295 publications with RB1 and Carcinoma
 Breast Neoplasms Antibodies  >124 publications with RB1 and Breast Neoplasms
 Adenocarcinoma Antibodies  >120 publications with RB1 and Adenocarcinoma
 Lung Neoplasms Antibodies  >89 publications with RB1 and Lung Neoplasms
 Neoplasms, Experimental Antibodies  >82 publications with RB1 and Neoplasms, Experimental
 Osteosarcoma Antibodies  >75 publications with RB1 and Osteosarcoma
 Liver Diseases Antibodies  >56 publications with RB1 and Liver Diseases
 Liver Neoplasms Antibodies  >47 publications with RB1 and Liver Neoplasms
 Necrosis Antibodies  >47 publications with RB1 and Necrosis

Organs/Tissues associated with RB1 blocking peptide

 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >307 publications with RB1 and Blood
 Eye Antibodies  >230 publications with RB1 and Eye
 Brain Antibodies  >208 publications with RB1 and Brain
 Lung Antibodies  >139 publications with RB1 and Lung
 Bone Antibodies  >108 publications with RB1 and Bone
 Liver Antibodies  >105 publications with RB1 and Liver
 Muscle Antibodies  >86 publications with RB1 and Muscle
 Skin Antibodies  >61 publications with RB1 and Skin
 Intestine Antibodies  >58 publications with RB1 and Intestine
 Prostate Antibodies  >55 publications with RB1 and Prostate